M

Mesa Obstetricians and Gynecologists | Research Department

Research site
(Unclaimed)
Location
7233 E. Baseline Road, Suite 101, Mesa, Arizona, United States of America

Site insights

Top conditions

Top treatments

BAY3427080
Elagolix
Elinzanetant
Estradiol
Fezolinetant
fezolinetant
MR-100A-01
Norethindrone Acetate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

This is phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menst...

Active, not recruiting
Uterine Fibroids
Heavy Menstrual Bleeding
Other: E2/NETA Placebo
Drug: E2/NETA
Locations recently updated

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling
Endometriosis
Drug: Elagolix
Drug: Placebo

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

Trial sponsors

AbbVie logo
Astellas logo
Bayer logo
Mylan logo
Organon logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems